New England Research & Management’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,625
Closed -$215K 183
2017
Q2
$215K Sell
1,625
-500
-24% -$64.1K 0.16% 149
2017
Q1
$252K Sell
2,125
-150
-7% -$17.6K 0.19% 147
2016
Q4
$267K Sell
2,275
-75
-3% -$8.91K 0.21% 141
2016
Q3
$284K Hold
2,350
0.24% 131
2016
Q2
$264K Sell
2,350
-75
-3% -$8.51K 0.23% 136
2016
Q1
$278K Sell
2,425
-150
-6% -$15.7K 0.24% 128
2015
Q4
$264K Sell
2,575
-275
-10% -$30K 0.23% 135
2015
Q3
$290K Buy
+2,850
New +$314K 0.28% 127

Other funds holding PX

New England Research & Management's PX Position: Q3 2017 in Review

New England Research & Management sold out of Praxair Inc (PX) in Q3 2017, closing a stake of 1,625 shares — an estimated $215K sold.

New England Research & Management first reported a position in PX in Q3 2015 and held it in 8 quarters. The position peaked at $290K in Q3 2015. 933 funds tracked by Wall St. Rank hold PX as of Q3 2017.

  • New England Research & Management reported no remaining Praxair Inc position as of Q3 2017 after selling out during the quarter.
  • New England Research & Management sold 1,625 Praxair Inc shares in Q3 2017, an estimated $215K.
  • New England Research & Management first reported a position in Praxair Inc in Q3 2015 and held it in 8 quarters.
  • New England Research & Management's Praxair Inc position peaked at $290K in Q3 2015.
  • 933 funds tracked by Wall St. Rank held Praxair Inc as of Q3 2017.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.